Kyle Lacio

Biomedical Engineer | BFS Line Technician at Nephron Pharmaceuticals Corporation | Former Naval Nuclear Reactor Operator | MBA Candidate | FINRA SIE & Series 6

[Kyle Lacio @KyleLacio]

I’m excited to join Nephron Pharmaceuticals and continue my work in biomedical engineering within the FDA cGMP pharmaceutical manufacturing space.

https://t.co/htUEE2m037

[The Wall Street Journal @WSJ]

Today, fewer than 200 humanoid robots are in the world’s factories. Up to 5 million could be in place by 2040.

[University of South Carolina College of Pharmacy @UofSCPharm]

Join us for 'Advanced Training in Sterile Compounding Essentials for Designated Persons,’ August 27-28, 2026.

💡 20-hour ACPE-accredited program includes home study + hands-on training in our ACE Lab in Columbia, SC

Register by August 13 ➡️ https://t.co/VXxxEEfyVt

[NIH Innovates @NIH_Innovates]

Big news for innovators, founders, and R&D-driven small companies: NIH’s Seed Fund is back in action!

Thanks to new legislation, U.S. small businesses are again able to pursue up to $1.4 billion per year in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding to power breakthrough science, build game-changing technologies, and move solutions toward real-world impact.

Start planning by checking out the funding opportunity forecasts on https://t.co/JIdnM0UYrB.

➡️Funding opportunity forecasts: https://t.co/gijf0XW9bZ
📌Key resources for applicants: https://t.co/t7QmAVRKp1

[Kyle Lacio @KyleLacio]

OpenAI Foundation's $100M Alzheimer's grant initiative:
1. Causal map of Alzheimer's
2. AI drug design & lab validation
3. Open datasets to predict drug activity
4. New biomarkers for diagnosis
5. Anonymized patient data review for off label treatments
https://t.co/4QLKZvEepa

[NVIDIA Healthcare @NVIDIAHealth]

🚀 The largest-ever open‑source protein‑complex treasure trove - 1.7 million of AI‑predicted complexes now live in the AlphaFold Database

In collaboration with @emblebi, @GoogleDeepMind, and @SeoulNatlUni, we have added millions of predicted complexes to the AlphaFold Database to accelerate global health research.
🧵👇

[Nephron Pharmaceuticals @NephronPharm]

Over 200 active drug shortages in the U.S. right now. Sterile injectables are hit hardest.

Nephron runs 24/7/365 in West Columbia, SC — over $500M invested, 840,000+ sq ft, 1B+ doses/year — because patients cannot wait.

#DrugShortage #AmericanManufacturing #NephronPharma

[Kyle Lacio @KyleLacio]

Nature featured brain organoids. I grew them. Spent 2 years in Dr. Daping Fan's lab developing a pilot iPSC-derived 3D organoid program for Alzheimer's drug testing. 3D organoids are a much closer model than mice or cell culture. Expect to see more of this in future research.

[nature @Nature]

Lab-grown organoids are turbo-charging the study of human brain development and disease

https://t.co/PVJEWaRUxa

[Markus Covert Lab @MarkusCovertLab]

Very true - it's time to call for a Human Cell Project, analogous to the Human Genome Project, to systematically and comprehensively characterize and model first the simplest and then the most complex cells. A moonshot to catapult biology to the next era🦠🚀💪 - let's go!!

[Congressman Nathaniel Moran @RepNateMoran]

America relies on China for up to 90% of key drug ingredients—putting our supply and national security at risk. We must rebuild U.S. manufacturing, boost innovation, and confront this challenge head-on to keep lifesaving medicines made in America.

[NASA @NASA]

We're going farther than ever before 🚀

Today, the Artemis II crew will break the record for how far humans have traveled from Earth as they fly around the far side of the Moon.

Coverage begins at 1 p.m. EDT (1700 UTC). Watch Artemis II make history: https://t.co/G7LpghURjg

[Samuel Hume @DrSamuelBHume]

What's bigger, GLP1s or AI?

[Kyle Lacio @KyleLacio]

Astronauts posting on Twitter on the way to the moon. This is so exciting. We're going back to the moon!

[Reid Wiseman @astro_reid]

There are no words.

[Nature Reviews Drug Discovery @NatRevDrugDisc]

FDA approves GLP-1 pill for obesity https://t.co/aPweiMvg14

Eli Lilly’s orforglipron is the first small-molecule GLP-1 receptor agonist to secure approval, offering a potential convenience edge over established peptidic GLP-1-based obesity drugs

[Kyle Lacio @KyleLacio]

@zachpippin @epicgardening Is the utility crew going to fix it when they are done?

[Kyle Lacio @KyleLacio]

This study showed antithymocyte globulin (ATG) was able to suppress the autoimmune destruction of the pancreas in newly diagnosed children age 5-25 with Type 1 diabetes. Protecting insulin producing function.
https://t.co/ujbQFdYUZ5

[Senator Tim Scott @SenatorTimScott]

Sickle cell disease affects thousands of Americans.

With new gene therapies offering real hope, I’m urging the FDA to revisit a decision denying a Priority Review Voucher for a curative therapy. We need policies that encourage innovation and give patients access to life-saving treatments! https://t.co/eI5QUad9Kr

[Kyle Lacio @KyleLacio]

PK/PD (Pharmacokinetics/Pharmacodynamics) modeling integrates how the body processes a drug (PK: absorption, distribution, metabolism, excretion) with the drug’s biological effect on the body (PD: efficacy, toxicity).

[Forbes @Forbes]

This Startup Wants To Use Mini Robots To Treat Alzheimer's

MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.
Read more: https://t.co/cESsMi1j0s

[Nephron Pharmaceuticals @NephronPharm]

Q1 done.
We didn't take a day off.
We never do.
24/7/365 from West Columbia, SC. 🇺🇸
#NephronPharma #AmericanManufacturing #MadeInUSA

[Kyle Lacio @KyleLacio]

In The Design of Everyday Things, Don Norman explains that when something is confusing, it’s usually because the design is bad not because the user did something wrong.

Good engineering is easy to understand right away.
Bad engineering makes people feel confused or frustrated.